Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (1.41%) to 10227.33, DAX (0.74%) to 24433.06, CAC40 +0.05% to 8203.43, STOXX 600 (0.50%) to 618.64

Jun 09 ,2026

  • Synopsis:

    • European equity markets ended the day mixed, with pan-European indices giving up all the early gains after Wall Street turned lower, the slide accelerating on both sides of the Atlantic into the EU close.

    • Sentiment was initially aided by an easing in Middle East tensions.

    • Greece +1.4% and Ireland +0.7% led outperformers. Finland (0.8%) joined the DAX and FTSE100 in leading underperformers.

    • In central banks, Bundesbank's Köhler-Geib was amongst the panellists at Jacques Delors Friends of Europe Foundations event Single Market Summit 2026, whilst Croatia central bank presented latest issue of the bank's Financial Stability publication. Riksbank's published its latest business survey and Estonia central bank held a press conf in connection with the recent IMF staff official visit

    • ECB's Lagarde hosting an informal dinner and exchange of views at 18:30CET with EU Commissioner for Climate, Net Zero and Clean Growth Hoekstra.

    • Economic news flow included UK's CBI lowering its forecast for GDP in 2026 and 2027 and expects inflation to increase towards +4% by the end of 2026, whilst Germany released Apr industrial production as well as trade balance.

    • In politics, PMs of the Baltic States and Nordic countries (NB8) met in Estonia, post meeting press conf (livestream) where France's Macron had participated via videoconf. in the session on regional security and defense. In the UK, MPs debate the remaining stages of the Steel Industry (Nationalisation) Bill whilst committee topics included financial inclusion strategy, the work of the ministry of housing, communities and local government, a one-off session on defence on Ukraine, the relationship between the Government and the defence industry, China and the UK economy and fiscal devolution in England.

    • EU's von der Leyen gave the opening speech at the New European Bauhaus Festival 2026. In the evening, Chancellor Merz hosts World Economic Forum President Zwinggi and around 50 members of the "Leaders for European Growth and Competitiveness" initiative. Norway's PM Støre will host a dinner with Kenya's President Ruto.

    • EU's Kubilius spoke at the event 'Europe's New Security Architecture: Ukraine as a Strategic Pillar of the Continent's Defence Future' whilst EU's Jørgensen, others, in a fireside chat at EUSEW 2026. Also, EU Telecom ministers met

    • Other events include IATA Slot Conf (through Thu) and Global Mobility Call (through Thu). Fitch Ratings held webinars on Global Renewables Projects: Credit Trends, Rating Pressures & Regional Insights (APAC/EMEA) as well as for NA/LATAM. Ljubljana and Zagreb Stock Exchanges hosts CEE Investment Opportunities.

    • Amongst the handful of company earnings/updates wea SoftwareONE Holding (SWON.SW) setting new 2030 financial targets including EBITDA margin above 28% - CMD.

    • M&A news flow included GSK (GSK.LN) agreeing to acquire Nuvalent, Inc. for $124/share in cash in a $10.6B deal, Sitowise Group to sell its Swedish subsidiary to Sweco for ~€3.0M (enterprise value) and Kona BidCo completes cash tender offer for Zalaris (ZAL.NO), will make a mandatory offer to acquire the remaining shares. Also, EU clears KBC Group (KBC.BB) and Van Lanschot Kempen Investment Banking's (VLK.NA) 50/50 equities activities JV and reportedly, PAI Partners withdraws from bidding for Nestle's (NESN.SW) water business and UniCredit (UCG.IM) eyes Delfin ~17.5% stake in MPS to block Intesa Sanpaolo takeover plan.

    • Elsewhere, reports suggested Germany and France had agreed to abandon development of the joint fighter aircraft under the Future Combat Air System (FCAS) defense program, with Airbus (AIR.FP) planning to announce a German-led alliance to replace doomed fighter jet at the ILA Berlin Air Show. Also, AstraZeneca (AZN.LN) announces elecoglipron moves to Phase III program and RAG-Stiftung launches an offering of bonds exchangeable into shares of Evonik Industries (EVK.GR)

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Chemicals +1.97%, Food & Beverage +1.93%, Retail +1.50%, Persnl & HHold Goods +1.42%, Insurance +0.78%, Real Estate +0.63%, Utilities +0.25%, Media +0.02%, Travel & Leisure (0.04%), Health Care (0.06%)

      • Underperformers:

        • Basic Resources (2.49%), Oil & Gas (2.39%), Telecom (2.00%), Ind Goods & Svcs (1.29%), Technology (1.28%), Banks (0.87%), Construct & Mtls (0.67%), Financial Svcs (0.55%), Autos & Parts (0.53%)

    • Macro/Peripheral markets:

      • G7:

        • France's Macron to host G7 video call with China on global trade imbalances ahead of Evian summit - Politico

      • EU:

        • Statement by President von der Leyen on the 21st sanctions package against Russia - release

        • EU to mobilise up to €25B for renewable energy and clean technology by 2035 through Pact for the Mediterranean initiative - release

      • Finland:

        • Following the funding round, the State of Finland will own ~ 12% of ICEYE - press release

        • Forest and nature information strategy completed - information strengthens sustainable forest use and biodiversity - release

      • Greece:

        • Government spokesperson rejects early election talk - ekathimerini

      • Norway:

        • Norway and Italy have today signed a letter of intent on a strategic industrial partnership - release

      • Sweden:

        • The economic situation is still weak and uncertainty around the war in the Middle East has increased again, which the companies say risks delaying the already prolonged recovery - Riksbank survey

      • Ukraine:

        • Zelensky reports positive call with US envoys as Europe backs proposed Putin meeting for ceasefire - France24

      • UK:

        • UK GSP forecast 2026 +1.1% vs prior +1.3% and 2027 +0.9% vs prior +1.5% - Confederation of British Industry (CBI) press release

        • Starmer vows to fight leadership challenge as Makerfield by-election looms - Politico

        • UK government to reimburse visa fees for tech and scale-up firms to attract talent - Bloomberg

        • Investors warn Scotland against long-term bonds over independence risk premium - FT

        • Cross-party group of UK lawmakers have warned government must overhaul property taxes if it is serious about helping first-time buyers and supporting economy - London Times

        • Andy Burnham made an election pledge to crack down on crime during campaigning in the Makerfield by-election - Manchester Evening News

    • Company news:

      • Notable Gainers

        • +243.0% ALZCUR.SS (AlzeCure Pharma) -- enters into a collaboration and out-licensing agreement with Eli Lilly for ACD680

        • +16.3% GROW.LN (Molten Ventures)

          • reports FY NAVPS 760.0p vs year-ago 671.0p

          • Molten Ventures's portfolio company ICEYE Oy completes primary Series F financing round of ~€450M; Molten's holding value in ICEYE will increase to £317M

          • Participates in Isar Aerospace signs a €270M Series D round

        • +6.6% PTP.GR (Pentixapharm Holding) -- FDA grants "Study May Proceed" for Phase 3 Study for PentixaFor; to issue up to 10M shares and pubishes BaFin Financial Reporting Enforcement Review

        • +5.7% INSTAL.SS (Instalco) -- installation order worth NOK112M

        • +5.6% FEVR.LN (Fevertree Drinks) -- AGM Trading Statement; remains confident of achieving full-year market expectations; announces further £30M extension of share buyback

        • +4.5% CEM.IM (Cementir Holding) -- announces agreement with Danish Energy Agency to receive carbon capture subsidy for ACCSION

        • +4.5% JLP.LN (Jubilee Metals Group) -- updates on Molefe Mine operation

        • +4.4% IDIA.SW (Idorsia) -- announces up to CHF250M loan from Pharmakon

        • +3.4% HAUTO.NO (Höegh Autoliners) - May trading update: 1.2M cbm of transported cargo on prorated basis

        • +3.2% BREE.LN (Breedon Group) -- completes acquisition of Falling Springs Quarry for EV of $120M (£90M)

        • +2.7% BMPS.IM (Banca Monte dei Paschi di Siena) -- initiates preliminary assessment of offers from Banco BPM and Intesa Sanpaolo

        • +2.7% BWY.LN (Bellway) -- trading update to 29-May; on track to deliver FY26 underlying operating profit within previously guided range of £320-330M

        • +2.4% BNZL.LN (Bunzl) -- outperform from neutral at BNP Paribas Exane

        • +2.4% OTB.LN (On The Beach Group) -- buy from hold at Shore Capital Stockbrokers

        • +2.2% HFD.LN (Halfords Group) -- initiated buy at Shore Capital Stockbrokers

          • On earnings/updates: AZM.IM (Azimut Holding), KLR.LN (Keller Group)

      • Notable Decliners

        • -28.9% LBG.LN (LBG Media) -- H1 revenue £52.4M, +19% vs year-ago £43.9M, pretax income £1.8M vs year-ago £8.6M, lowers FY guidance

        • -11.4% RUSTA.SS (Rusta) -- Q4 EPS (SEK0.40) vs FactSet (SEK0.23) [3 est, (SEK0.34)-(0.14)]

        • -9.0% OXIG.LN (Oxford Instruments)

          • reports FY adj EPS from cont ops 100.7p vs FactSet 95.3p [7 est, 93.6-97.0p]; hikes divi by +6.3%

          • downgraded to hold from buy at Shore Capital Stockbrokers

        • -8.2% GLE.LN (MJ Gleeson) -- announces slippage into FY27 of previously disclosed land sales; FY26 trading in Gleeson Homes is in line with management's expectations

        • -7.3% DATA.LN (GlobalData) -- initiated neutral at JPMorgan

        • -4.8% BIOPOR.DC (BioPorto) -- intends to initiate the ProNephro AKI U.S. Adult Urine NGAL Validation Study following FDA feedback; clearance is now expected mid-2028

        • -3.8% IDR.SM (Indra Sistemas) -- German and France agree to abandon development of the joint fighter aircraft under the Future Combat Air System (FCAS) defense program - Reuters

        • -3.7% NANO.LN (Nanoco Group) -- notes Glass Lewis recommends voting for delisting resolution at next week's general meeting

        • -3.0% SWON.SW (SoftwareONE Holding) -- new 2030 financial targets - CMD; shares reversed initial gains

        • -2.7% SDF.GR (K+S) -- launches offering of ~€300M convertible bonds due 2031

          • On earnings/updates: reversing initial gains ANIM.IM (Anima Holding)

    • EU companies reporting tomorrow:

      • Earnings:

        • DACHs: MPH Health Care (93M1.GR)

        • France: Figeac Aero (FGA.FP)

        • Nordics: Systemair (SYSR.SS)

        • UK: Pennon Group (PNN.LN), Workspace Group (WKP.LN), Fuller, Smith & Turner (FSTA.LN), Vp (VP.LN), H-Power (HPOW.LN), Motorpoint Group (MOTR.LN)

      • Trading Update:

        • UK: WH Smith (SMWH.LN), Frontier Developments (FDEV.LN)

      • Traffic: Flughafen Zuerich (FHZN.SW)

      • CMD/Events: Evonik Industries (EVK.GR) innovation press conf at 9:30CET, Volkswagen Group (VOW.GR) ESG Conf at 15:00CET, Volvo Group (VOLV.B.SS) at 9:00CET

  • Data:

    • Economics:

      • UK May LFL retail sales +3.4% vs consensus +0.8%, prior (3.4%) - British Retail Consortium (BRC) release

      • Netherlands May CPI +3.5% vs preliminary +3.5%

      • Denmark Apr

        • Manufacturing production (1.1%) m/m vs consensus (2.9%), prior revised +8.3% from +8.6%

        • Trade balance DKK32.8B vs consensus DKK29.9B, prior revised DKK31.4B from DKK33.8B

      • Norway May PPI +24.0% y/y vs consensus +26.0%, prior +22.7%

      • Germany Apr

        • Industrial production +0.4% m/m vs consensus +0.4%, prior revised (0.1%) from (0.7%)

        • Trade balance €14.5B vs consensus €15.4B, prior revised €14.7B from €14.3B

    • Markets:

      • WTI Crude (Jul 26): ($3.54) or (3.88%) to $87.76

      • €-$ +0.0017 or +0.15% to 1.1550

      • £-$ +0.0036 or +0.27% to 1.3377

      • €-£ (0.0012) to 0.8634

      • S&P 500 (1.07%)

      • Performance year-to-date:

        • FTSE 100: +2.98%

        • DAX: (0.23%)

        • CAC: +0.66%

        • MIB: +11.83%

        • Stoxx 600: +4.47%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.